Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Infection and Immunity|October 1, 1971
Micro complement fixation assay for type-specific group A streptococcal antibodyM K Wittner, E N FoxInfection and Immunity|January 1, 1977
Homologous and heterologous protection of mice with group A streptococcal M protein vaccinesM K Wittner, E N FoxThe Journal of Experimental Medicine|August 1, 1977
Streptococcal-induced cell-mediated-immune destruction of cardiac myofibers in vitroL C Yang, P R Soprey, M K Wittner, et al.The Journal of Clinical Investigation|August 1, 1973
Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteersE N Fox, R H Waldman, M K Wittner, et al.The Journal of Infectious Diseases|December 1, 1978
Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A StreptococcusR D'Alessandri, G Plotkin, R M Kluge, et al.Infection and Immunity|February 1, 1976
Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypesM K WittnerJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1982
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodiesM K Wittner, M A Bach, H KöhlerThe Journal of Infectious Diseases|March 1, 1975
Protective studies with a group A streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tractS M Polly, R H Waldman, P High, et al.Developments in Biological Standardization|January 1, 1975
Group A streptococcal M protein vaccine: protection following immunization via the respiratory tractR H Waldman, J D Lee, S M Polly, et al.Pageof 1